NuVasive 3Q17 Revenue +3.2% vs. 3Q16

NuVasive (NUVA) reported 3Q17 revenue of US $247.4MM, +3.2% vs. 3Q16, and year-to-date revenue of $757.9MM, +9.7% vs. the prior year. Estimated segment sales and growth follow.

3Q17 Geographic growth: U.S. $200.9MM, -3.5%; ex-U.S. $46.4MM, +48.1%

$ Change ...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us